Supernus Pharmaceuticals, Inc.

SUPN·NASDAQ·$47.77Share Price as of 11/2·$3BMarket Cap as of 11/2

Financials

10-QQ3 ended 09/30/2610/29/26 10-QQ2 ended 06/30/2608/03/26 10-QQ1 ended 03/31/2605/05/26 10-KFY 202503/02/26 10-QQ3 ended 09/30/2511/06/25

Disclosures

8-KCurrent report10/29/26 8-KCurrent report10/26/26 8-KCurrent report10/22/26 8-KCurrent report10/19/26 8-KCurrent report10/15/26

Prospectuses and Registrations

S-8Registration of securities for employees06/22/26 S-8 POSPost-effective amendment (S-8)02/24/25 S-8Registration of securities for employees06/17/24 S-8Registration of securities for employees06/25/21 S-8Registration of securities for employees06/26/20

Proxies

DEFA14AAdditional proxy materials10/06/26 DEFM14ADefinitive proxy (merger)09/11/26 DEFA14AAdditional proxy materials08/03/26 DEFA14AAdditional proxy materials08/03/26 DEFA14AAdditional proxy materials08/03/26

Ownership

Form 4Insider transaction08/14/26 Form 4Insider transaction08/14/26 Form 4Insider transaction08/14/26 Form 4Insider transaction08/14/26 Form 4Insider transaction08/14/26

Other

42542510/06/26 42542508/03/26 42542508/03/26 42542508/03/26 ARSAnnual report to shareholders04/30/26